Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics

The emergence and re-emergence of highly virulent viral pathogens with pandemic potential creates an urgent need for the accelerated discovery of antiviral therapeutics. Antiviral human monoclonal antibodies (mAbs) are promising candidates to prevent or treat severe viral diseases, but their long de...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilchuk, Pavlo, Bombardi, Robin G., Erasmus, Jesse H., Tan, Qing, Nargi, Rachel, Soto, Cinque, Abbink, Peter, Suscovich, Todd J, Durnell, Lorellin A., Khandhar, Amit, Archer, Jacob, Liang, Jenny, Fouch, Mallorie E., Davidson, Edgar, Doranz, Benjamin J., Jones, Taylor, Larson, Elise, Ertel, Stacey, Granger, Brian, Fuerte-Stone, Jasmine, Roy, Vicky, Broge, Thomas, Linnekin, Thomas C., Linde, Caitlyn H., Gorman, Matthew J., Nkolola, Joseph, Alter, Galit, Reed, Steven G., Barouch, Dan H., Diamond, Michael S., Crowe, James E., Van Hoeven, Neal, Thackray, Larissa, Carnahan, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655621/
https://www.ncbi.nlm.nih.gov/pubmed/32747832
http://dx.doi.org/10.1038/s41551-020-0594-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655621/
https://www.ncbi.nlm.nih.gov/pubmed/32747832
http://dx.doi.org/10.1038/s41551-020-0594-x

Ejemplares similares